BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases	Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Immunoglobulin G4-Related Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sjogren syndrome, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, acquired thrombotic thrombocytopenic purpura, anterior uveitis, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, blood coagulation disease, blood platelet disease, cardiovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, hematologic disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, panuveitis, purpura, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura, uveal disorder, uveitis, vascular disorder, vasculitis	Recruiting	Phase 2	2025-04-02		NCT06794008

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking University People's Hospital	269

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Rheumatology and Immunology, Peking University People's Hospital	Beijing	China	4